Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

NCT04390984 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Apatinib Mesylate, Gefitinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.